SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is currently facing intense selling pressure as a major analyst firm highlighted significant downside risk due to deteriorating financial metrics and weakening EV demand. Community sentiment is deeply divided, with some investors panic-selling into the decline, while others continue to debate the stock's future value based on the potential impact of Elon Musks focus shifting toward private ventures like SpaceX.

Enovix Corp. engages in the design and development of silicon-anode lithium-ion batteries. The firm's proprietary 3D cell architecture increases energy density and maintains a high cycle life. It is also developing its 3D cell technology and production process for the electric vehicle and energy storage markets to help enable utilization of renewable energy. The company was founded by Mr. Harrold Jones Rust, III, Ashok Lahiri, and Murali Ramasubramanian in November 2006 and is headquartered in Fremont, CA.

Enovix Corporation

Enovix Corp

Enovix is currently trending as investors debate the company's long-term commercial viability versus its ongoing manufacturing challenges at the Fab2 facility. While some community members are highlighting the potential of the Meta-Bounds partnership and high-energy-density silicon-anode technology, others remain focused on the stock hitting all-time lows and express frustration over the lack of major purchase orders.

Aehr Test Systems engages in the design, manufacture, market, and sale of test and burn-in equipment used in the semiconductor industry. Its products include FOX-XP, FOX-NP, and FOX-CP wafer contact parallel test and burn-in systems, the WaferPak full wafer contactor, the DiePak Carrier, the WaferPak Aligner, the DiePak Autoloader, and test fixtures. The company was founded by Rhea J. Posedel on May 25, 1977 and is headquartered in Fremont, CA.

Aehr Test Systems

Aehr Test Systems is seeing a surge in investor attention as the community anticipates major contract announcements linked to its role as a key reliability gatekeeper for AI infrastructure. Traders are closely monitoring the stock's proximity to all-time highs and watching for potential updates on follow-on orders following recent positive guidance and increased interest from hyperscale data center partners.

The Aircoin memecoin was born from a viral Twitter post from March, 2014 which proclaimed the following:   Evolution: 1. Aircoin 2. Fartcoin 3. Artcoin  Aircoin was launched in August, 2025 and CTO'd twice, with the second CTO team bringing vast experience and expertise to the project. The team includes industry veterans and visual arts professionals.  Aircoin is destined for greatness as a premier memecoin on the BONK.fun platform.

aircoin

The Aircoin community is driving significant momentum on Solana, emphasizing a long-term, conviction-based approach characterized by voluntary supply locks and consistent development. Supporters are actively promoting the token as a resilient, community-led alternative to the typical cycle of short-lived meme coin volatility.

Mega Fortune Co., Ltd. operates as a holding company which provides information technology services. It specializes in delivering comprehensive IoT solutions and services across various industries. The firm offers low carbon property management, energy, stock and GreenTech management services. The company was founded in 2011 and is headquartered in Hong Kong.

Mega Fortune Co Ltd.

Mega Fortune Company Limited

Mega Fortune Company Limited is trending as traders speculate on its potential for a parabolic short squeeze, drawing heavy comparisons to past Chinese low-float runners. While momentum players are actively accumulating shares and highlighting thin liquidity, a significant portion of the community remains highly skeptical, labeling the stock a typical pump-and-dump scheme prone to volatility and sudden halts.

The Wendy’s Co. engages in operating, developing, and franchising a system of quick-service restaurants. It operates through the following segments: Wendy’s U.S., Wendy’s International, and Global Real Estate and Development. The Wendy’s U.S. segment includes the operation and franchising of Wendy’s restaurants in the U.S. The Wendy’s International segment is involved in the operation and franchising of Wendy’s restaurants in countries and territories other than the U.S. The Global Real Estate and Development segment focuses on real estate activity for owned sites and sites leased from third parties. The company was founded by R. David Thomas on November 15, 1969 and is headquartered in Dublin, OH.

Wendy`s Co - Ordinary Shares - Class A

Wendy's Co

Wendy's is currently a focal point for investors due to heavy short interest, widespread speculation regarding a potential privatization or buyout deal, and an aggressive international expansion strategy. Community discussion remains polarized, with many retail traders actively accumulating shares and advocating for a short squeeze while others express frustration over the delayed CEO search and inconsistent store performance.

Viridian Therapeutics, Inc. is a biopharmaceutical company that develops medicines for autoimmune and rare diseases. It uses antibody discovery and protein engineering to create new therapies. The company is advancing late-stage IGF-1R therapies for thyroid eye disease (TED) and developing a potential TSHR-targeted treatment for TED and Graves’ disease. In addition, it is developing FcRn inhibitors, including VRDN-006 and VRDN-008, for multiple autoimmune diseases. The company was founded by William S. Marshall and Bruce L. Booth in February 2006 and is headquartered in Waltham, MA.

Viridian Therapeutics Inc

Viridian Therapeutics is facing significant market volatility as investors weigh disappointing Phase 3 trial data against the company's long-term potential in the thyroid eye disease space. While the community is actively debating the competitive threat posed by Amgen's recent successes and questioning the efficacy of Viridian's subcutaneous treatment profile, some traders view the recent sell-off as an overreaction, pointing to a robust pipeline and upcoming catalysts that could trigger a rebound.

Avino Silver & Gold Mines Ltd. engages in the mining and exploration activities. It focuses on silver reserves in the Durango region of North Central Mexico. It operates through the Silver, Gold, and Copper segments. The company was founded on May 15, 1968 and is headquartered in Vancouver, Canada.

Avino Silver & Gold Mines Ltd.

Avino Silver & Gold Mines is trending as investors digest strong quarterly earnings and operational momentum, fueled by high metal prices and the company's recent move to secure full ownership of its La Preciosa project. The community is actively discussing the stock's inclusion in major indices and monitoring its growth as a key player in the silver sector, with many analysts and traders closely watching for further institutional interest and production updates.

FUST (Fusion token) is the companion token of FUSD - with tokenomics which mirror those of a typical cryptocurrency. FUST can be placed in the FUST Fusion Miner and used to mine free FUSD. FUST has tokenomics which mirror those of a typical cryptocurrency, and allows those Degens who buy into the FUSD philosophy - but who also enjoy the thrill of chasing fast green candles - to make their play within the structure of the FUSD ecosystem and benefit from the best of both worlds; the possibility of a fast ride upwards whilst earning a passive income paid in our appreciating stable token courtesy of their FUST bag.

FUST Token

The FUST token is trending as the community highlights the upcoming NFT platform launch and the unique utility of its ecosystem, which includes the appreciating FUSD stablecoin. Investors are actively discussing the project's consistent delivery of passive income rewards and expressing optimism about its potential for long-term growth and upcoming community distributions.

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.

Replimune Group Inc

Replimune Group is trending due to the upcoming April 10 PDUFA date for RP1, with the community deeply divided between bullish investors betting on FDA approval following the recent BLA resubmission and bearish traders anticipating a second Complete Response Letter (CRL) based on historical efficacy concerns. Discussions are heavily focused on the high-stakes binary nature of this regulatory event, with many participants debating the potential for a share price collapse or a short squeeze given the significant short interest and volatile options flow.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

HC Wainwright Issues Pessimistic Outlook for ABEO Earnings

Abeona Therapeutics Inc. (NASDAQ:ABEO - Free Report) - Equities researchers at HC Wainwright decreased their Q1 2026 EPS estimates for Abeona Therapeutics in a report released on Thursday, March 19th. HC Wainwright analyst R. Selvaraju now anticipates that the biopharmaceutical company will post ear...

Abeona Therapeutics (NASDAQ:ABEO) Earns Buy Rating from HC Wainwright

HC Wainwright reiterated a "buy" rating and issued a $20.00 price target on shares of Abeona Therapeutics in a research report on Thursday...

Abeona Therapeutics Q4 Earnings Call Highlights

Abeona Therapeutics (NASDAQ:ABEO) executives said the company is seeing growing patient demand for ZEVASKYN, an autologous cell-based gene therapy approved in April 2025 for adults and pediatric...

Abeona Therapeutics (NASDAQ:ABEO) Releases Quarterly Earnings Results, Misses Expectations By $0.01 EPS

Abeona Therapeutics (NASDAQ:ABEO - Get Free Report) issued its quarterly earnings data on Tuesday. The biopharmaceutical company reported ($0.34) EPS for the quarter, missing analysts' consensus...

Abeona Therapeutics Inc. $ABEO Shares Sold by Boone Capital Management LLC

Boone Capital Management LLC decreased its holdings in shares of Abeona Therapeutics Inc. (NASDAQ:ABEO - Free Report) by 59.9% during the third quarter, according to its most recent disclosure with...

Q4 EPS Forecast for Abeona Therapeutics Increased by Analyst

Abeona Therapeutics Inc. (NASDAQ:ABEO - Free Report) - Stock analysts at HC Wainwright boosted their Q4 2025 EPS estimates for shares of Abeona Therapeutics in a research note issued on Tuesday...

Abeona Therapeutics Says ZEVASKYN Launch Is Back on Track, Eyes Profitability in 2026

Abeona Therapeutics (NASDAQ:ABEO) executives said the commercial launch of ZEVASKYN is gaining momentum after an early manufacturing-related delay, outlining progress on treatment center activation...

HC Wainwright Reaffirms "Buy" Rating for Abeona Therapeutics (NASDAQ:ABEO)

HC Wainwright reiterated a "buy" rating and issued a $20.00 price objective on shares of Abeona Therapeutics in a research report on Tuesday...

Abeona Therapeutics (ABEO) Projected to Post Earnings on Tuesday

Abeona Therapeutics (NASDAQ:ABEO) will be releasing its Q4 2025 earnings before the market opens on Tuesday, March 17. (View Earnings Report at...

Abeona Therapeutics Inc. $ABEO Shares Sold by Western Standard LLC

Western Standard LLC lowered its holdings in Abeona Therapeutics Inc. (NASDAQ:ABEO - Free Report) by 40.2% during the third quarter, according to the company in its most recent filing with the SEC...

Abeona Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of gene therapy for severe and life-threatening rare diseases. It programs include EB-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (RDEB), ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA), and ABO-101 (AAV NAGLU), an AAV based gene therapy for Sanfilippo syndrome type B (MPS IIIB). The company was founded in 1974 and is headquartered in Cleveland, OH.

Current Price	$4.74
Prev Close	$4.82
Open	$4.88
Dividend Yield	0.00%
50-Day Moving Average	$4.93
Beta	0.67
Avg. Volume	1.49M
PE Ratio	4.83

52-Week High	$7.54
52-Week Low	$3.93
Market Capitalization	$274.98M
EPS (Annual)	$1.01
Price to Book	1.67
Revenue Per Employee	$25,752.21

ABEO
Abeona Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ABEO News

ABEOAbeona Therapeutics Inc